Clinical Trials Browser

Phase 2/3 × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT03822845 2025-04-17

Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer

Phase 2/3 Completed

6 enrolled 8 charts

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT03389451 2024-07-12

68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

Phase 2/3 Completed

30 enrolled 10 charts

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT03388346 2024-02-15

68Ga PSMA in Preprostatectomy Patients

Phase 2/3 Completed

22 enrolled 15 charts

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant